Cappella Inc. Secures US$17.3 Million Series C Investment.
PR Newswire Europe, June, 2009
WILMINGTON, Delaware and GALWAY, Ireland, June 15 /PRNewswire/ --
- New and existing investors complete a US$17.3 million Series C
investment
- Experienced medical device executive, Dr. Art Rosenthal, appointed as
CEO
- Aggressive launch of Sideguard(TM) Sidebranch stent in EU following
recent CE Marking
- Expansion of management team, R&D and manufacturing capacity in Galway,
Ireland
Cappella, Inc. (Cappella) announces today that it has completed a US$17.3 million Series C investment, led by new investors, Fountain Healthcare Partners and Mitsui & Co. Venture Partners (MCVP). Enterprise Ireland also participated in this round alongside Cappella's existing investors, Polytechnos Partners and ACT...
Premium Content Partnership |
HighBeam Research provides an in-depth online archive library of reference works.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
Presented by American Express